National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 3885 [2025-00851]
Download as PDF
<![CDATA[
3885
Federal Register / Vol. 90, No. 9 / Wednesday, January 15, 2025 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
2,500
1
10/60
417
.............................
....................
18,548
........................
3,209
Totals ..........................................................................
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Investigator Initiated
Extended Clinical Trial (R01 Clinical Trial
Required) and NIAID Clinical Trial
Implementation Cooperative Agreement (U01
Clinical Trial Required).
Date: February 12, 2025.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G13A,
Rockville, MD 20892 (Video Assisted
Meeting).
Contact Person: Mairi Noverr, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G13A, Rockville, MD
20892, (240) 747–7530, mairi.noverr@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
VerDate Sep<11>2014
18:37 Jan 14, 2025
Jkt 265001
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: January 10, 2025.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
Bruce A. George,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2025–00851 Filed 1–14–25; 8:45 am]
BILLING CODE 4140–01–P
[FR Doc. 2025–00688 Filed 1–14–25; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
lotter on DSK11XQN23PROD with NOTICES1
Individuals ...........
7—NIH Extended Visitor Form (Generic) ..........................
[FR Doc. 2025–00650 Filed 1–14–25; 8:45 am]
Total
annual
burden
(in hours)
Number of
responses per
respondent
Type of
respondent
Dated: January 3, 2025.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
Average
burden per
response
(in hours)
Number of
respondents
Form name
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; NHLBI
Mentored Clinical and Basic Science Study
Section.
Date: February 27–28, 2025.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Manoj Kumar
Valiyaveettil, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA,
National Heart, Lung, and Blood Institute,
National Institutes of Health, 6705 Rockledge
Drive, Room 208–R, Bethesda, MD 20817,
(301) 402–1616, email: manoj.valiyaveettil@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
PO 00000
Frm 00099
Fmt 4703
Sfmt 9990
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Aging
Research.
Date: February 21, 2025.
Time: 10:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institute on Aging, 5601
Fishers Lane, Suite 8B, Rockville, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Anita T. Tandle, Ph.D.,
Scientific Review Officer, National Institute
on Aging, National Institutes of Health, 5601
Fishers Lane, Suite 8B, Rockville, MD 20892,
(240) 204–0329, tandlea@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: January 10, 2025.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2025–00849 Filed 1–14–25; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\15JAN1.SGM
15JAN1
]]>Agencies
[Federal Register Volume 90, Number 9 (Wednesday, January 15, 2025)]
[Notices]
[Page 3885]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-00851]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Investigator Initiated Extended
Clinical Trial (R01 Clinical Trial Required) and NIAID Clinical
Trial Implementation Cooperative Agreement (U01 Clinical Trial
Required).
Date: February 12, 2025.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G13A,
Rockville, MD 20892 (Video Assisted Meeting).
Contact Person: Mairi Noverr, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities,
National Institute of Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, Room 3G13A, Rockville, MD
20892, (240) 747-7530, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: January 10, 2025.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2025-00851 Filed 1-14-25; 8:45 am]
BILLING CODE 4140-01-P
